Home Newsfeeds Caleres Reiterates FY22 Outlook

Caleres Reiterates FY22 Outlook

Caleres still expects the following for fiscal year 2022: Consolidated sales up between 4 percent and 6 percent compared to fiscal 2021; Adjusted earnings per share

byBenzinga Newsdesk

January 9, 2023

1 minute read

Caleres still expects the following for fiscal year 2022:

Consolidated sales up between 4 percent and 6 percent compared to fiscal 2021;
Adjusted earnings per share between $4.30 and $4.40; and
Consolidated inventory up mid-single digit percent compared to fiscal year 2021.

This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday

By Lisa Levin

July 22, 5:04 AM

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023.

Jefferies Maintains Hold on Hartford Finl Servs Gr, Lowers Price Target to $72

By Benzinga Newsdesk

July 12, 10:49 AM

Jefferies analyst Yaron Kinar maintains Hartford Finl Servs Gr (NYSE:HIG) with a Hold and lowers the price target from $77 to $72.

HIG

Why Asbury Automotive Group Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

October 24, 2:12 PM

Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares climbed 169% to $1.56 after the company announced it selected a lead Alzheimer's drug candidate following proof-of-concept study data.

AAN